 |
For Immediate Release Contact: Antipsychotic Drugs Increase Risk of Developing Pneumonia in Elderly Utrecht, The Netherlands - April 15, 2008 - Elderly patients who use antipsychotic drugs have a 60 percent increased risk of developing pneumonia compared to non-users. This risk of developing pneumonia is the highest in the first week following prescription and decreases gradually thereafter. These findings are published in Journal of the American Geriatrics Society. Antipsychotic drugs are frequently used in elderly patients for the treatment of psychosis and behavioral problems associated with dementia and delirium. This study is the first to show that the development of pneumonia is associated with antipsychotic drug use. "The risk of developing pneumonia is not associated with long-term use, but is the highest shortly after starting the drug," say Drs. Rob van Marum and Wilma Knol, authors of the study. They caution that "all antipsychotic drugs may be associated with pneumonia in elderly patients." In nursing homes, up to 40 percent of residents may be prescribed antipsychotics, according to the study. It has been suggested that, for residents of nursing homes who receive antipsychotic therapy, more than half are prescribed for inappropriate reasons. Although literature shows limited efficacy and effectiveness for antipsychotic drug use in the treatment of behavioral problems in dementia patients, these drugs are frequently used for this purpose. In the last few years it has become clear that the use of antipsychotic drugs in elderly patients is also associated with an increased risk of death and morbidity. The underlying mechanism for the association remains unclear. The authors stress that clinicians may need to monitor patients for sedation after initiation of antipsychotic medication and that a careful weighing of the possible risks is recommended before starting antipsychotic treatment in elderly people. This study is published in Journal of the American Geriatrics Society. Media wishing to receive a PDF of this article may contact medicalnews@bos.blackwellpublishing.net. Rob van Marum, M.D., Ph.D. is a geriatrician and clinical pharmacologist in the department of Geriatrics at University Medical Center Utrecht. Dr. van Marum can be reached for questions at r.j.vanmarum@umcutrecht.nl. Wilma Knol, M.D. is a geriatrician in the TerGooi hospital in Hilversum, the Netherlands. Dr. Knol can be reached for questions at w.knol@umcutrecht.nl. To view the abstract for this article, please click here. 
The Journal of the American Geriatrics Society is a comprehensive and reliable source of monthly research and information about common diseases and disorders of older adults. For more information, please visit www.blackwellpublishing.com/jgs. Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley's Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,400 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit www.blackwellpublishing.com or http://interscience.wiley.com. |
 |